Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v2-FR
Language English French
Date Updated 2020-06-30 2020-06-29
Drug Identification Number 02187108 02187108
Brand name SYNPHASIC 21 TABLETS SYNPHASIC 21 TABLETS
Common or Proper name SYNPHASIC 21 SYNPHASIC 21
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients NORETHINDRONE ETHINYL ESTRADIOL NORETHINDRONE ETHINYL ESTRADIOL NORETHINDRONE ETHINYL ESTRADIOL NORETHINDRONE ETHINYL ESTRADIOL
Strength(s) 0.5MG 0.035MG 1.0MG 0.035MG 0.5MG 0.035MG 1.0MG 0.035MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 21's 21's
ATC code G03AB G03AB
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-06-29 2020-06-29
Estimated end date 2020-10-09 2020-10-09
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments Limited inventory available and on preventative allocation. Other presentation available: SYNPHASIC 1/0.035mg TAB 1x28 BLST Limited inventory available and on preventative allocation. Other presentation available: SYNPHASIC 1/0.035mg TAB 1x28 BLST
Health Canada comments